ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,274.75
0.20%
Dow Jones
44,722.06
-0.31%
Gold vs US Dollar
2,635.775
0.13%
Brent Oil
72.395
-0.08%
Bitcoin
95,980.82
4.36%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kintara Therapeutics Inc (KTRA)

  7. Kintara Therapeutics Inc (KTRA) News

Kintara Therapeutics (KTRA)

Kintara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KTRA
DateTimeSourceHeadlineSymbolCompany
25/11/202413:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
15/11/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
14/11/202422:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:KTRAKintara Therapeutics Inc
14/11/202422:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KTRAKintara Therapeutics Inc
14/11/202421:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
25/10/202420:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
25/10/202420:28Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
25/10/202420:26Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
25/10/202420:23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:KTRAKintara Therapeutics Inc
25/10/202420:20Edgar (US Regulatory)Form SC 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:KTRAKintara Therapeutics Inc
23/10/202401:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202400:50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202400:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202400:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202400:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202400:38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202400:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
23/10/202400:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
22/10/202423:56Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KTRAKintara Therapeutics Inc
21/10/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
16/10/202416:54PR Newswire (US)Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024NASDAQ:KTRAKintara Therapeutics Inc
16/10/202415:58PR Newswire (US)Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA BiosciencesNASDAQ:KTRAKintara Therapeutics Inc
16/10/202404:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KTRAKintara Therapeutics Inc
15/10/202420:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
15/10/202420:15PR Newswire (US)Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024NASDAQ:KTRAKintara Therapeutics Inc
15/10/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
14/10/202412:30PR Newswire (US)Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024NASDAQ:KTRAKintara Therapeutics Inc
08/10/202420:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:KTRAKintara Therapeutics Inc
08/10/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
08/10/202411:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KTRAKintara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:KTRA

Your Recent History

TSXV
AFR
Nuventure Resources
BIT
P1U514
BNP Paribas Issuance
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 35%, 2 years 45% and *3 years 60%

    *Across 3 years £2132.64 only £853.06